The leaflet can provide basic information about induction of labour (IOL) and DILAPAN-S to women undergoing IOL procedure. This print version is tailored for BW printing. For print in colour please find digital version.

The leaflet can provide basic information about induction of labour (IOL) and DILAPAN-S to women undergoing IOL procedure. For digital use. For print purposes, please fint print version in both colour and black-and-white.

RCT (randomised clinical trial) COMRED compared DILAPAN-S with low dose oral misoprostol (25 mcg a 2 hours).

Leaflet also exists in German and French.

RCT (randomised clinical trial) SOLVE compared DILAPAN-S with Propess (dinoprostone vaginal insert).

Leaflet also exists in German and French.

RCT (randomised clinical trial) DILAFOL compared DILAPAN-S with Foley catheter.

Leaflet also exists in German and French.

RCT (randomised clinical trial) HOMECARE evaluated DILAPAN-S efficacy, safety, and maternal satisfaction in out-patient use.

The leaflet describes DILAPAN-S mode of action, summarizes key benefits and offers example of DILAPAN-S clinical protokol. Leaflet also exists in German and French.

First part of the presentation provides brief introduction of company MEDICEM, followed by overview of DILAPAN-S and IOL (induction of labour) market. Second part offers you an example of 2022 European communication strategy, incl. unmet needs and DILAPAN-S key benefits.

Overview leaflet of DILAPAN-S savings. Learn how DILAPAN-S incurs significant cost and time savings; A newly published 4-page literature summary of recent RCTs, economic analyses, and case studies demonstrates cost and time savings, with additional savings for outpatient inductions.